Cargando…

Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart disease

PURPOSE: To evaluate the efficacy and safety of intravenous sildenafil for immediate postoperative pulmonary hypertension (PH) in pediatric patients undergoing congenital heart surgery. METHODS: A double-blind, multicenter, placebo-controlled, dose-ranging, parallel-group trial was conducted. Patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fraisse, Alain, Butrous, Ghazwan, Taylor, Mary B., Oakes, Michael, Dilleen, Maria, Wessel, David L.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Original
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042092/ https://www.ncbi.nlm.nih.gov/pubmed/21069290 http://dx.doi.org/10.1007/s00134-010-2065-4

Ejemplares similares

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Schistosomiasis and pulmonary arterial hypertension
por: Butrous, Ghazwan
Publicado: (2014)

Pulmonary hypertension: From an orphan disease to a global epidemic
por: Butrous, Ghazwan
Publicado: (2020)

Saudi guidelines on the treatment and management of pulmonary hypertension 2014: Updates a fresh understanding of pulmonary vascular diseases in the developing world
por: Butrous, Ghazwan
Publicado: (2014)

Does intravenous sildenafil clinically ameliorate pulmonary hypertension during perioperative management of congenital heart diseases in children? – A prospective randomized study
por: Sharma, Vipul Krishen, et al.
Publicado: (2015)

Intravenous sildenafil in right ventricular dysfunction with pulmonary hypertension following a heart transplant
por: Bonet, Luis Almenar, et al.
Publicado: (2014)

Intravenous sildenafil for treatment of early pulmonary hypertension in preterm infants
por: Schroeder, Lukas, et al.
Publicado: (2023)

Schistosome infection and its effect on pulmonary circulation
por: Butrous, Ghazwan
Publicado: (2019)

The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases
por: Butrous, Ghazwan
Publicado: (2014)

Readership: The heart of Pulmonary Circulation
por: Yuan, Jason X.J., et al.
Publicado: (2013)

Oral versus intravenous sildenafil for pulmonary hypertension in neonates: a randomized trial
por: Chetan, Chinmay, et al.
Publicado: (2022)

Sildenafil for congenital heart diseases induced pulmonary hypertension, a meta-analysis of randomized controlled trials
por: Awad, Ahmed K., et al.
Publicado: (2023)

Infection in pulmonary vascular diseases: Would another consortium really be the way to go?
por: Butrous, Ghazwan, et al.
Publicado: (2019)

Sildenafil in the treatment of pulmonary hypertension
por: Barnett, Christopher F, et al.
Publicado: (2006)

The role of preoperative sildenafil therapy in controlling of postoperative pulmonary hypertension in children with ventricular septal defects
por: Bigdelian, Hamid, et al.
Publicado: (2017)

Sildenafil in pediatric pulmonary arterial hypertension
por: Dhariwal, AK, et al.
Publicado: (2015)

Significant intrapulmonary Schistosoma egg antigens are not present in schistosomiasis-associated pulmonary hypertension
por: Graham, Brian B., et al.
Publicado: (2011)

Comparison of intravenous sildenafil with inhaled nitric oxide for acute vasodilator testing in pulmonary arterial hypertension
por: Kumar, Shine, et al.
Publicado: (2022)

Use of sildenafil in late postoperative period of congenital diaphragmatic hernia
por: Falcão, Mário Cícero, et al.
Publicado: (2021)

International cooperation to promote advances in medicine
por: Butrous, Ghazwan
Publicado: (2008)

Remembering Almaz Aldashev: one of the founders of the PVRI
por: Butrous, Ghazwan
Publicado: (2017)

Safety and Efficacy of Sildenafil for Group 2 Pulmonary Hypertension in Left Heart Failure
por: Desai, Kinjal, et al.
Publicado: (2023)

Safety and tolerability considerations in the use of sildenafil for children with pulmonary arterial hypertension
por: Dodgen, Andrew L, et al.
Publicado: (2015)

Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension
por: Beghetti, Maurice, et al.
Publicado: (2017)

Pharmacokinetic and Pharmacodynamic Comparison of Sildenafil‐Bosentan and Sildenafil‐Ambrisentan Combination Therapies for Pulmonary Hypertension
por: Hakamata, A, et al.
Publicado: (2016)

The world of pulmonary vascular disease
por: Yuan, Jason X.-J., et al.
Publicado: (2011)

Gut microbiota crosstalk mechanisms are key in pulmonary hypertension: The involvement of melatonin is instrumental too
por: Jacobs, Steve, et al.
Publicado: (2023)

Diagnostic dilemma in a child with congenital heart disease on sildenafil
por: Zaki, Syed Ahmed, et al.
Publicado: (2009)

Is Sildenafil an Effective Therapy in the Management of Persistent Pulmonary Hypertension?
por: Yaseen, Hakam, et al.
Publicado: (2012)

Bosentan and sildenafil in the treatment of HIV-associated pulmonary hypertension
por: Chinello, Pierangelo, et al.
Publicado: (2011)

Sildenafil in endotoxin-induced pulmonary hypertension: an experimental study
por: Kemper, Daniella Aparecida Godoi, et al.
Publicado: (2021)

Pulmonary hypertension in the developing world: Local registries, challenges, and ways to move forward
por: Idrees, Majdy, et al.
Publicado: (2020)

Segmental Pulmonary Hypertension in Children with Congenital Heart Disease
por: Das, Bibhuti B., et al.
Publicado: (2020)

Science is an endless frontier: Encouraging translational research in pulmonary vascular disease
por: Yuan, Jason X.-J., et al.
Publicado: (2012)

Efficacy, safety and tolerability of bosentan as an adjuvant to sildenafil and sildenafil alone in persistant pulmonary hypertension of newborn (PPHN)
por: Vijay Kumar, J.R., et al.
Publicado: (2021)

Pulmonary Circulation : A new venue for communicating your findings, ideas and perspectives
por: Yuan, Jason X.-J., et al.
Publicado: (2011)

Pleiotropic effects of statins in distal human pulmonary artery smooth muscle cells
por: Ali, Omar F, et al.
Publicado: (2011)

Pulmonary arterial size and response to sildenafil in chronic thromboembolic pulmonary hypertension
por: Toshner, Mark R., et al.
Publicado: (2010)

Intra-amniotic sildenafil treatment improves lung blood flow and pulmonary hypertension in congenital diaphragmatic hernia rats
por: Yoshida, Shiho, et al.
Publicado: (2023)

The CoDiNOS trial protocol: an international randomised controlled trial of intravenous sildenafil versus inhaled nitric oxide for the treatment of pulmonary hypertension in neonates with congenital diaphragmatic hernia
por: Cochius-den Otter, Suzan, et al.
Publicado: (2019)

Comparison of preventive effect of sildenafil and therapeutic effect of sildenafil treatment in rats with monocrotaline-induced pulmonary arterial hypertension
por: YOSHIYUKI, Rieko, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jctnnes82qhc20fho0810jvnaq